RCSB PDB - 9PL Ligand Summary Page

Chemical Component Summary
Name	(3S,4R)-3-ethyl-4-[(1-methyl-1H-imidazol-5-yl)methyl]dihydrofuran-2(3H)-one
Identifiers	(3S,4R)-3-ethyl-4-[(3-methylimidazol-4-yl)methyl]oxolan-2-one
Formula	C₁₁ H₁₆ N₂ O₂
Molecular Weight	208.26
Type	NON-POLYMER
Isomeric SMILES	CC[C@H]1[C@H](COC1=O)Cc2cncn2C
InChI	InChI=1S/C11H16N2O2/c1-3-10-8(6-15-11(10)14)4-9-5-12-7-13(9)2/h5,7-8,10H,3-4,6H2,1-2H3/t8-,10-/m0/s1
InChIKey	QCHFTSOMWOSFHM-WPRPVWTQSA-N

Chemical Details
Formal Charge	0
Atom Count	31
Chiral Atom Count	2
Bond Count	32
Aromatic Bond Count	5

Drug Info: DrugBank

DrugBank ID	DB01085
Name	Pilocarpine
Groups	approved investigational
Description	A slowly hydrolyzed muscarinic agonist with no nicotinic effects. Pilocarpine is used as a miotic and in the treatment of glaucoma.
Synonyms	Pilocarpine nitrate Pilocarpine Pilocarpina Pilocarpine hydrochloride
Brand Names	ACAT SUK Kit (Accelerated COVID-19 Antibody Test Single Use Kit) Miocarpine Oph Soln 4% Betoptic Pilo Miocarpine Ophthalmic Solution 4% Pilocarpine Hydrochloride 4% - Liq Oph Miocarpine Oph Soln 2% E-pilo-4 Oph Soln Isopto Carpine Timpilo 2 PMS-pilocarpine 4% Miocarpine Oph Soln 6% Pilopine Hs Salagen Pilocarpine 4% Pilocarpine Hydrochloride Ophthalmic Solution 2% USP Accel-pilocarpine Minims Pilocarpine Nitrate 2% PMS-pilocarpine 6% E-pilo 1 Ophthalmic Solution Pilocarpine 1% PMS-pilocarpine 0.5% Pilocarpine Hydrochloride 1% - Liq Oph Pilocarpine Hydrochloride Odan-pilocarpine Miocarpine Ophthalmic Solution 1% Pilocarpine Hydrochloride Ophthalmic Solution 4% USP Minims Pilocarpine Nitrate 4% Isopto Carpine Liq 6% R.O.-carpine 4% E-pilo-6 Oph Soln Ocusert Pilo 20 Pilocarpine 6% Pilocarpine Hydrochloride Tablets Pilocarpine Hydrochloride Ophthalmic Solution 1% USP Betoptic/pilo pilocarpine Hydrochloride Pilocarpine Hydrochloride Tablets, USP Pilocarpine Hydrchloride Pilocarpine PMS-pilocarpine 2% Isopto Carpine 0.5% Pilopine Hs 4% Ocusert Pilo 40 R.O.-carpine 2% Miocarpine Oph Soln 1% E-pilo 4 Ophthalmic Solution Miocarpine Ophthalmic Solution 2% Miocarpine Ophthalmic Solution 6% Pilocarpine 2% E-pilo-1 Oph Soln PMS-pilocarpine 1% Pilocarpine Hydrochloride 2% - Liq Oph R.O. -carpine 1% E-pilo-2 Oph Soln E-pilo 6 Ophthalmic Solution E-pilo 2 Ophthalmic Solution Timpilo 4 Pilocarpine hydrochloride
Indication	For the treatment of radiation-induced dry mouth (xerostomia) and symptoms of dry mouth in patients with Sjögrens syndrome.
Categories	Alkaloids Antiglaucoma Preparations and Miotics Autonomic Agents Cholinergic Agents Cholinergic Agonists Cholinergic Receptor Agonist Cytochrome P-450 CYP2A6 Inhibitors Cytochrome P-450 CYP2A6 Inhibitors (strong) Cytochrome P-450 CYP3A Inhibitors Cytochrome P-450 CYP3A4 Inhibitors Cytochrome P-450 CYP3A4 Inhibitors (strength unknown) Cytochrome P-450 Enzyme Inhibitors Miotics Muscarinic Agonists Nervous System Neurotransmitter Agents Ophthalmologicals Parasympathomemetic (Cholinergic) Agents Parasympathomimetics Peripheral Nervous System Agents Sensory Organs
ATC-Code	N07AX01 S01EB01 S01EB51
CAS number	92-13-7

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
Muscarinic acetylcholine receptor M3	MTLHNNSTTSPLFPNISSSWIHSPSDAGLPPGTVTHFGSYNVSRAAGNFS...	unknown	agonist
Muscarinic acetylcholine receptor M1	MNTSAPPAVSPNITVLAPGKGPWQVAFIGITTGLLSLATVTGNLLVLISF...	unknown	agonist
Muscarinic acetylcholine receptor M2	MNNSTNSSNNSLALTSPYKTFEVVFIVLVAGSLSLVTIIGNILVMVSIKV...	unknown	agonist
Muscarinic acetylcholine receptor M4	MANFTPVNGSSGNQSVRLVTSSSHNRYETVEMVFIATVTGSLSLVTVVGN...	unknown	partial agonist
Cytochrome P450 2A6	MLASGMLLVALLVCLTVMVLMSVWQQRKSKGKLPPGPTPLPFIGNYLQLN...	unknown	inhibitor
Cytochrome P450 3A4	MALIPDLAMETWLLLAVSLVLLYLYGTHSHGLFKKLGIPGPTPLPFLGNI...	unknown	inhibitor
View More

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Resource Name	Reference
CCDC/CSD	PICGEH
PubChem	5910
ChEBI	CHEBI:8207
ChEMBL	CHEMBL550
Pharos	CHEMBL550

175282 Biological Macromolecular Structures Enabling Breakthroughs in Research and Education

9PL

(3S,4R)-3-ethyl-4-[(1-methyl-1H-imidazol-5-yl)methyl]dihydrofuran-2(3H)-one

Chemical Component Summary

Chemical Details

Drug Info: DrugBank

Drug Targets

Related Resource References

Prepare Data

Validate Data

Deposit Data

Deposition Help & Resources

175282 Biological Macromolecular Structures Enabling Breakthroughs in Research and Education

9PL

(3S,4R)-3-ethyl-4-[(1-methyl-1H-imidazol-5-yl)methyl]dihydrofuran-2(3H)-one

Chemical Component Summary

Chemical Details

Drug Info: DrugBank

Drug Targets

Related Resource References